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Results: Median GRACE in-Hospital and 6 month mortality score
was 139 and 131 respectively. The observed mortality showed
gradient according to GRACE risk score, being lowest in Low risk,
increased in Intermediate Risk and highest in High risk group.
In hospital and 6 month, Observed & anticipated mortality, HLp
value for calibration and C statistics for discrimination is shown in
Table.
The Hosmer-Lemeshow P-value between 0.31 to 0.51 shows that
the calibration power of GRACE score for observed against pre-
dicted, in-hospital as well as 6-month mortality is acceptable for
all subsets of ACS population.
C statistics of close to 0.8 shows good discrimination power of
GRACE risk score for all subgroups of ACS patients.
Conclusion: GRACE Score is accurate, with good calibration and
discrimination power to predict mortality in Indian ACS patients
and can be used for risk stratification and deciding the manage-
ment strategy.
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Background and Rationale: Dietary intervention in atherosclerosis
is difficult for reasons such as longer duration for the impact to be
evident, maintaining the compliance up to the end and to balance
the other contributing factors. This is the first study in literature on
the effect of cooking oil media on cardiovascular risk factors and
lipid profiles and cardiac events. This study evaluated the effect of
the most commonly used cooking media in the state of Kerala to
answer the question what oil to be used after cardiac events.
Design andMethods: Two hundred patients with proven coronary
artery disease on standard medical care were (100 each) assigned
to coconut oil or sunflower oil as a cooking oil media for 2 years.
Total 1200 clinical visits were carried out and collected data on
anthropometry, lipids, lipoproteins, antioxidants flow mediated
vasodilation and cardiac events.
Study compliance to a particular oil arm was assured by using 3
tools: 24 hour recall, 7 Day recall and diet dairy.
Results: Recruitments was completed in 3 yrs. The reason for the
delay were patient decision to change over to a particular oil.
Family acceptance of the need for special cooking pattern.
Consent to undergo study related visits and blood test.
99% patients in each arm adhered to the oil assigned. All pa-
tients completed the final visit. Except for the particular oil all
other factors including the calories derived from major foodstuff
were maintained equal in both groups.
There is no statistically significant difference in the anthropo-
metric, biochemical, vascular function and in cardiovascular
events in patients with CAD while using either coconut oil or
sunflower oil as cooking media over a period of 2 years.
Conclusion: Even though difficult for many reasons, long term
dietary interventions in atherosclerosis is possible with meticu-
lous planning and by using study compliance techniques.
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Background: Patients with diabetes have extensive CAD. Ranola-
zine is effective in treating angina andmay also improve glycemic
control. We conducted a randomized trial to test the antianginal
benefit of ranolazine in patients with diabetes and stable angina.
Objectives: Evaluate efficacy of ranolazineversusplacebo onangina
frequency and use of sublingual isosorbide dinitrate tablets in pa-
tients with type 2 Diabetes and stable angina who remain symp-
tomatic despite treatment with 1 or 2 anti-anginal medications.
Methods: This was a trial of ranolazine versus placebo in patients
with diabetes and stable angina treated with 1 to 2 antianginals.
185 patients were randomized to ranolazine and placebo group.
Anginal episodes and isosorbide dinitrate use were recorded with
daily entry into a diary. Primary outcome was the average weekly
number of anginal episodes over the last 6 weeks of the study.
Results: A total of 185 patients were randomized. Mean age was
62.35±1.18years, 58.92%weremen,meandiabetesdurationwas7.2
years, and mean baseline HbA1c was 6.75%. Weekly angina fre-
quency was significantly lower with ranolazine versus placebo (4.8
[95%confidence interval (CI): 4.6 to 5.1] episodesvs. 5.3 [95%CI: 5.0 to
5.5] episodes,p¼0.004), aswas theweeklysublingualnitrateuse (2.7
[95% CI: 2.6 to 2.9] doses vs. 3.1 [95% CI: 2.9 to 3.3] doses, p ¼ 0.002).
Conclusions: Among patients with diabetes and chronic angina,
ranolazine reduced angina and sublingual nitrate use and was
well tolerated.
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Table- Discrimination & Calibration power of GRACE score
Patient no. Observed
mortality %
Anticipated
mortality %
Hosmer-Lemeshow
P-value
C statistics AUC-ROC
(95% CI)
In-hospital
Total 516 4.84 4.4 0.51 0.80(0.78-0.81)
STEMI 159 8.1 7.7 0.43 0.81(0.78-0.81)
NSTEMI/UA 357 3.3 3.1 0.39 0.78(0.76-0.80)
6-month
Total 445 6.3 5.9 0.41 0.79(0.77-0.82)
STEMI 134 8.9 8.4 0.32 0.81(0.77-0.83)
NSTEMI/UA 311 5.1 4.8 0.31 0.77(0.74-0.82)
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